BioSTL fosters collaborative efforts and builds regional infrastructure to achieve St. Louis’ potential in biosciences. BioSTL issued the following News Update on August 27, 2012.
MediBeacon LLC, a new St. Louis-based optical diagnostic company has announced its initial round of funding.
BioSTL’s affiliate, the BioGenerator, provided business assistance and funding to MediBeacon through its i6 Challenge program that supports the launch of local bioscience startups. MediBeacon also received funding from St. Louis Development Corporation and Missouri Technology Corporation.
MediBeacon will utilize the shared laboratory facilities of the BioGenerator Accelerator Labs, and will have offices at the Center for Emerging Technologies.
Please see the attached press release from MediBeacon and coverage in the attached article from last week’s St. Louis Business Journal.
PDF version of MediBeacon press release
PDF of print edition article from St. Louis Business Journal, August 24, 2012
United States
425 N. New Ballas Road
Suite 100
St. Louis, MO 63141
P: (314) 735-0968
Germany
Cubex41
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
P: +49 (0)621-150283-15
Greater China
華東醫藥股份有限公司
聯繫電話:4008-269-985
+86-(0)571-89908581
郵遞區號:310011
地址:中國浙江省杭州市拱墅區莫幹山路866號
郵箱:info@eastchinapharm.com
* MediBeacon 的各個產品線均處於臨床開發的不同階段,尚未批准用於人體。
**經皮GFR監測系統(TGFR)用於檢查腎功能受損或正常人的腎絲球過濾率(GFR),本網站使用的文獻中涉及到的“腎臟功能”或者“腎功能”均指GFR檢測。
COOKIE CONSENT: We use cookies and similar technologies to recognize your repeat visits and preferences, as well as to analyze traffic, among other things. To learn more about cookies, view our Privacy Policy. By clicking “I Accept” on this banner, or using our site, you consent to the use of cookies unless you have disabled them.